Recent evidence suggests that admission hyperglycemia has deleterious effects on the survival and functional outcome of patients with intracerebral hemorrhage (ICH). In this study, we fi rst induced acute hyperglycemia in male adult Sprague-Dawley rats by intraperitoneal injection of 50% glucose (6 mL/kg), and created the ICH model thereafter by delivering autologous whole blood or homologous normalglucose blood into the right basal ganglia. Twentyfour hours later, we assessed the neurological injury, evaluated the hematoma and brain water content, and investigated autophagy. We found elevations of neurological deficit scores, brain water content, and microtubule-associated protein light chain-3 (LC3) and beclin-1 protein levels, and decreased SQSTM1/ p62 levels after ICH with normal-glucose blood (without hyperglycemia). Acute hyperglycemia with ICH of high-glucose blood hematoma was associated with significantly increased forelimb-use asymmetry test scores, brain water content and SQSTM1/p62 protein levels, and evident decreases in the ratio of LC3-II/LC3-I and beclin-1 protein levels. On the other hand, acute hyperglycemia and ICH with normalglucose blood hematoma only slightly increased the neurological deficit scores and brain water content (P >0.05). In conclusion, the autophagy pathway was activated after ICH, and acute hyperglycemia with hematoma of high-glucose blood exacerbates the neurological injury, and reduces autophagy around the hematoma.
INTRODUCTION
Intracerebral hemorrhage (ICH) accounts for 10-15% of all strokes worldwide and patients with ICH show the worst outcome of all stroke subtypes [1, 2] . Studies have indicated that hyperglycemia may worsen the prognosis of ICH patients in terms of functional recovery at discharge and one-month mortality [3] . However, the causal role and determinant effect of hyperglycemia in ICH remain unknown.
Autophagy has long been considered an important catabolic process that involves the delivery of cytoplasmic material to the lysosome for degradation and plays an important part in many human diseases [4] . Recent research has indicated that autophagy is activated after ICH, and may participate in the pathophysiological process of ICH.
He et al. [5] observed numerous autophagosomes in the perihematomal area. On the other hand, autophagy can be affected by high glucose levels. Kobayashi et al. [6] found that high glucose reduces autophagy in cultured cardiomyocytes. However, the effect of hyperglycemia on autophagy after ICH in vivo, and the exact role of autophagy in ICH remain unknown.
In the present study, we used an acute hyperglycemia rat model of ICH to determine its effects on neurological deficits and brain edema. Specifically, three reliable markers of autophagy were used, microtubule-associated protein light chain-3 (LC3), beclin-1, and SQSTM1/p62.
MATERIALS AND METHODS

Animals and Experimental Design
A total of 89 adult male Sprague-Dawley rats (provided by the Shanghai Laboratory Animal Co., Shanghai, China)
weighing 275-325 g were used; they were housed under a 12:12 h light/dark cycle (lights on from 08:00 to 20:00),
with free access to food and water. All experiments were approved by the Animal Care and Use Committee of Zhejiang University, and conformed to the guidelines of the "Principles of Laboratory Animal Care" (NIH publication
No. 80-23, revised 1996) . Utmost efforts were made to minimize the number of animals used and their suffering.
Rats were randomly divided into fi ve groups, (1) ICH model (group I) without acute hyperglycemia, (2) sham (group S), (3) acute hyperglycemia + ICH with normalglucose blood hematoma (group IG1), which received a 50% glucose (6 mL/kg) injection (intraperitoneal, i.p.)
followed by an infusion of homologous blood from another rat with normal blood glucose; (4) acute hyperglycemia + ICH with high-glucose blood hematoma (group IG2), which received a glucose injection followed by an infusion of autologous blood; and (5) hyperglycemia (group G), receiving only a glucose i.p. injection. The glucose was injected 30 min before the ICH. All rats were fasted overnight before the experiments and sacrifi ced 24 h after the operation.
ICH Model
The rats were anesthetized with pentobarbital (45 mg/kg, i.p.) and placed in a stereotaxic frame. A 1-mm-diameter burr hole was drilled in the skull (0.2 mm anterior and 3.5 mm lateral to bregma) and a needle was lowered into the right caudate nucleus (6 mm below the skull surface). Blood (100 μL) was collected from the right femoral artery and then delivered into the right caudate nucleus at 10 μL/min by a micropump. The needle was left in place for 10 min to prevent blood refl ux. Core temperature was maintained at 37°C throughout the surgery, and recovery was assisted using an electric heating pad.
Behavioral Tests
The corner-turn and forelimb-use asymmetry tests were conducted before and 24 h after operation according to the previous description [7] .
Corner-Turn Test
The rat was allowed to move into a 30°
corner, and then turned left or right to get out of the corner.
This was repeated 10 times, and the test score was the percentage of right turns.
Forelimb-Use Asymmetry Test
The rat was observed 
Hematoma Assessment
Under pentobarbital anesthesia (45 mg/kg, i.p.), each rat was intracardially perfused with PBS and the brain removed 24 h after operation. Coronal slices (2 mm thick) were prepared, and each slice was digitized. A region of interest was traced around the perimeter of the hematoma, and the hematoma area was quantifi ed using ImageJ software.
Brain Water Content
Rats were decapitated under pentobarbital anesthesia 24 h after operation. The brain was immediately removed and a coronal slice (~4 mm thick) 4 mm from the frontal pole was cut. The slice was divided into hemispheres along the midline, and the cortex and basal ganglia of each hemisphere were dissected out. The cerebellum was also detached to serve as a control. Brain samples were immediately weighed on an electronic analytical balance to obtain the wet weight. The samples were then dried at 100°C for 24 h to obtain the dry weight. The brain water content was calculated as follows: (wet weight -dry weight)
/wet weight × 100%.
Western Blot
The brain samples were homogenized with radioimmunoprecipitation assay lysis buffer (Beyotime Institute of Biotechnology, Shanghai, China). Protein concentration was determined using a bicinchoninic acid protein assay kit were visualized with a chemiluminescence system (Merck Millipore; cat. no: WBKLS0500) and exposed to Kodak X-OMAT fi lm.
Immunohistochemistry
Twenty-four hours after the operation, the rats were anesthetized (pentobarbital, 45 mg/kg, i.p.) and perfused through the heart with 100 mL PBS followed by 120 mL fi xative (4% paraformaldehyde in 0.1 mol/L PBS, pH 7.4). or monoclonal mouse anti-SQSTM1 antibody (1:150; Origene). They were then incubated with the secondary antibody for 60 min. Subsequently, the sections were rinsed, and diaminobenzidine was added for coloration.
After hematoxylin counterstaining, dehydration, clearing and coverslipping, the sections were observed under a light microscope (Olympus, CX41).
Statistical Analysis
Values are presented as mean ± SD. Statistical comparisons between groups were performed using Student's t-test or one-way analysis of variance, followed by the Student-Newman-Keuls test for comparisons across multiple groups. P <0.05 was considered statistically signifi cant.
RESULTS
Plasma Glucose Levels
Plasma glucose markedly increased 30 min after the i.p. injection of 50% glucose. Without any treatment, the plasma glucose levels in the hyperglycemia pre-treatment groups (groups G, IG1, and IG2) returned to normal 24 h after the operation (Fig. 1 ). After an infusion of 100 μL autologous blood into the right basal ganglia, the plasma glucose levels still fl uctuated within the normal range.
Acute Hyperglycemia and ICH with High-glucose Blood Hematoma Exacerbated the Neurological Defi cit
There were no statistical differences among the groups prior to operation (Fig. 2) . Twenty-four hours after the operation, ICH was associated with neurological deficits (Group I vs Group S: corner-turn test score, 92 ± 11.35% vs 51 ± 7.38%, P <0.01; forelimb-use asymmetry test score, 33.5 ± 7.84% vs -0.5 ± 7.98%, P <0.01). ICH with or without hyperglycemia increased the corner-turn test scores, which approached 100% (92 ± 11.35% in group I vs 96 ± 9.66% in group IG2, P >0.05; Fig. 2A ). In the IG1
group, the forelimb-use asymmetry test score tended to increase compared with the I group, but with no signifi cant difference (42.0 ± 10.85% vs 33.5 ± 7.84%, P >0.05; Fig. 2B ). In contrast, acute hyperglycemia and ICH with high-glucose blood hematoma (group IG2) resulted in a significantly higher forelimb-use asymmetry test score than group I (53.5 ± 11.07% vs 33.5 ± 7.84%, P <0.05; Fig. 2B ).
Acute Hyperglycemia and ICH with High-glucose Blood Hematoma Exacerbated Brain Edema
There were no statistical differences in hematoma size among the I, IG1, and IG2 groups 24 h after ICH (Fig. 3) . Acute hyperglycemia only (group G) did not affect the water content of the ipsilateral basal ganglia compared with the sham group (78.28 ± 0.49% vs 78.34 ± 0.51%, P >0.05) (Fig. 4) . However, 24 h after the ICH operation (group I), edema occurred (79.66 ± 0.52% vs 78.34 ± 0.51%, P <0.05). When only the serum glucose was elevated (group IG1), the brain water content increased slightly after ICH, compared with the I group (80.12 ± 0.54% vs 79.66 ± 0.52%, P >0.05). But autophagosome membranes [8] . Beclin-1 (Atg6) is essential for the recruitment of ATGs to autophagosomes and the induction of autophagosome formation [9] . The SQSTM1/p62
protein is selectively incorporated into autophagosomes through direct binding to LC3, and is efficiently degraded Fig. 5 ).
The staining of LC3-and beclin-1-positive cells was weak in the sham and G groups. However, 24 h after ICH, LC3-and beclin-1-positive cells were deeply stained around the hematoma. Consistent with the results of the Western blot analysis, we found that acute hyperglycemia and ICH with normal-glucose blood hematoma did not markedly change the LC3 and beclin-1 staining compared with the ICH group, but acute hyperglycemia and ICH with highglucose blood hematoma weakened the staining (Fig. 6 ).
Moreover, SQSTM1/p62-positive cells were deeply stained in the sham and G groups. However, 24 h after ICH, the p62 staining around the hematoma was weakened.
Consistent with the results of Western blot analysis, we found that acute hyperglycemia and ICH with normalglucose blood did not markedly change the SQSTM1/ p62 staining, but acute hyperglycemia and ICH with highglucose blood deepened it (Fig. 6 ).
DISCUSSION
In this study, we found that autophagy occurred in the ipsilateral basal ganglia 24 h after ICH. Acute hyperglycemia together with ICH hematoma of highglucose blood aggravated the neurological deficits and brain edema, and reduced autophagy around the hematoma after ICH.
Acute Hyperglycemia and ICH with High-glucose Blood Hematoma Exacerbated Neuronal Injury after ICH
Admission hyperglycemia, which frequently occurs after ICH, is induced by diabetes mellitus or a stress response.
It is considered to be a predictor of poor outcome, and is potentially related to the presence and severity of intraventricular extension [11] [12] [13] . Animal studies have also
shown that persistent hyperglycemia induced by an i.p.
injection of streptozotocin exacerbates cerebral hematoma expansion, and causes more profound brain edema and perihematomal cell death after ICH [14, 15] . Earlier studies found that diabetes or chronic hyperglycemia induces microvasculature lesions, including in the cerebral vessels [16] , which may be partly responsible for the deleterious effects of persistent hyperglycemia on ICH. In this study, we used a transient hyperglycemia rat model by i.p. administration of a 50% glucose solution, and without any treatment, the plasma glucose levels of the acutely hyperglycemic rats returned to normal 24 h after operation.
Therefore, the potential effects of hyperglycemia-induced lesions in cerebral vessels prior to ICH were excluded and we assumed that the results refl ected the effects of acute hyperglycemia on ICH.
Our results showed that acute hyperglycemia and ICH with high-glucose blood hematoma exacerbated the neurological deficits. This is in line with a previous report which showed that admission hyperglycemia is associated with poor functional recovery at discharge after ICH [3] .
In addition, recent studies have indicated that preischemic hyperglycemia exacerbates brain damage [17, 18] because hyperglycemia worsens blood-brain barrier (BBB) injury after ischemia [19] . In our study, we found that an increase only in serum glucose slightly elevated the neurological deficit scores and brain water content, although the changes were not statistically signifi cant. The deleterious effects induced by acute hyperglycemia may also be associated with the exacerbated breakdown of the BBB after ICH. When the serum glucose and glucose levels in the hematoma were both increased, the neurological deficit scores and brain water content were significantly elevated, which indicated that increased glucose levels in the hematoma play a role in brain injury. Nishikawa et al. [20] also found that hyperglycemia increases the production of reactive oxygen species in vitro.
Autophagy Pathway Was Activated after ICH, But
Acute Hyperglycemia and ICH with High-glucose Blood
Hematoma Reduced Autophagy around the Hematoma
Autophagy is essential for homeostasis and cell survival, and has been implicated in many diseases [21] [22] [23] . We found that the autophagy pathway was activated after ICH, which is consistent with recent studies [5] . However, it remains controversial as to whether autophagy is harmful or beneficial after ICH. The answer may depend on the physiological or pathological environment around the cells and the level of autophagy. In myocardial ischemiareperfusion injury experiments, although the induction of autophagy during the myocardial ischemic phase is protective, further enhancement of autophagy during the myocardial reperfusion phase appears to be detrimental and may induce cell death [24] . Thrombin and iron are confi rmed aggravating factors in ICH. Hu et al. [25] found that thrombin activates autophagy in the brain. Furthermore, 3-methyladenine, an autophagy inhibitor, exacerbates thrombin-induced cell death in cultured astrocytes, which infers that autophagy is protective. However, a recent report indicated that the intracerebral infusion of iron activates autophagy, and deferoxamine (an iron chelator) signifi cantly reduces autophagy after ICH, which suggests that iron-induced autophagy plays a role in brain injury [5] .
Thus, further investigation is required and direct evidence is needed to determine the functional role of autophagy in ICH.
The findings of the present study indicated that an increase in serum glucose alone did not affect autophagy around the hematoma after ICH, but acute hyperglycemia and ICH with high-glucose blood hematoma reduced autophagy. It seems that autophagy around the hematoma after ICH is mainly infl uenced by local high-glucose blood.
Similar results have been found in cultured cardiomyocytes, in which high glucose reduces autophagy compared with normal glucose levels [6] . However, the mechanism of decreased autophagy in vivo may also be associated with the secretion of insulin induced by acute hyperglycemia;
and Prod'home et al. found that insulin inhibits autophagy in vitro [26] .
Reduced autophagy may only be an epiphenomenon of neurological injury, which is exacerbated by acute hyperglycemia and ICH with high-glucose blood hematoma.
Another possibility is that decreased autophagy may 
